Evidence map›Paper›PMID 15187123›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2004

A two-step model of acute CD4 T-cell mediated cardiac allograft rejection.

Todd J Grazia, Biagio A Pietra, Zachary A Johnson, Brian P Kelly, Robert J Plenter, Ronald G Gill

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. CD4 T cells mediate cardiac xenograft rejection via host MHC Class II.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2012
    Article
  10. Article
  11. Prolongation of cardiac allograft survival by a novel population of autologous CD117+ bone marrow-derived progenitor cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2011
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Todd J GraziaDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Denver, CO 80262, USA.
Biagio A Pietra
Zachary A Johnson
Brian P Kelly
Robert J Plenter
Ronald G Gill

Funding

UCHSC DIABETES ENDOCRINOLOGY RESEARCH CENTERP30DK057516 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HUTTON, JOHN C · 2000 to 2010
$14.0M
REVERSAL OF DIABETES BY ISLET TRANSPLANTATIONR01DK033470 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI GILL, RONALD G · 1986 to 2006
$2.1M
CD4 T cell Dependent Acute Cardiac Allograft RejectionR01HL067976 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI PIETRA, BIAGIO A · 2001 to 2004
$1.2M
Antigen Presentation in CD4-mediated Cardiac RejectionF32HL074694 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GRAZIA, TODD J · 2003 to 2003
$56k
NHLBI NIH HHS F32 HL 074694NHLBI NIH HHS F32 HL074694NHLBI NIH HHS R01 HL067976NHLBI NIH HHS R01 HL 67976NIDDK NIH HHS P30 DK057516NIDDK NIH HHS P30 DK 57516NIDDK NIH HHS R01 DK033470NIDDK NIH HHS R01 DK 33470
6 · The paper itself

Abstract

CD4 T cells are both necessary and sufficient to mediate acute cardiac allograft rejection in mice. This process requires "direct" engagement of donor MHC class II molecules. That is, acute rejection by CD4+ T cells requires target MHC class II expression by the donor and not by the host. However, it is unclear whether CD4+ T cell rejection requires MHC class II expression on donor hemopoietic cells, nonhemopoietic cells, or both. To address this issue, bone marrow transplantation in mice was used to generate chimeric heart donors in which MHC class II was expressed either on somatic or on hemopoietic cells. We report that direct recognition of hemopoietic and nonhemopoietic cells are individually rate limiting for CD4+ T cell-mediated rejection in vivo. Importantly, active immunization with MHC class II(+) APCs triggered acute rejection of hearts expressing MHC class II only on the somatic compartment. Thus, donor somatic cells, including endothelial cells, are not sufficient to initiate acute rejection; but they are necessary as targets of direct alloreactive CD4 T cells. Taken together, results support a two-stage model in which donor passenger leukocytes are required to activate the CD4 response while direct interaction with the somatic compartment is necessary for the efferent phase of acute graft rejection.

Indexed as

Acute DiseaseAdoptive TransferAnimalsAntigen-Presenting CellsBone Marrow TransplantationCD4-Positive T-LymphocytesEndothelial CellsGraft RejectionHeart TransplantationHistocompatibility Antigens Class IIMiceMice, KnockoutTransplantation ChimeraTransplantation, HomologousHistocompatibility Antigens Class II

Identifiers

PMID15187123
PMCPMC4427250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.